Programme/Approved Electives for 2025/26
None
Available as a Free Standing Elective
No
The module will introduce the drug development pipeline from in-silico studies to clinical trials. You will apply knowledge of biological and chemical structures to explore principles of pharmacokinetics and pharmacodynamics in modern drug discovery. Specific examples of biological targets and drug molecules will be discussed, where you will develop higher-level skills in accessing and manipulating structural information for ligand-target interactions. You will also further develop teamwork and communication skills, including to non-specialist audiences.
Aims
To expand core level 4 biological chemistry material and its application to drug design and development. Students will be introduced to the drug development pipeline through to clinical trials and emerging technologies in drug design, as well as principles of pharmacodynamics and pharmacokinetics, and the physicochemical properties of drugs/ligands and their molecular interactions with biological targets.
Talis Aspire Reading ListAny reading lists will be provided by the start of the course.http://lists.lib.keele.ac.uk/modules/lsc-20087/lists
Intended Learning Outcomes
explain the principles of the drug discovery pipeline from candidate selection through to clinical trials: 3explain basic concepts of pharmacokinetics and pharmacodynamics and their importance to drug delivery, potency and selectivity: 1,2,3describe the molecular interactions between drugs/ligands and their targets in biological systems: 1,3evaluate the structures of molecules related to their suitability as therapeutic agents and discuss approaches to ligand-based drug design through structure-activity relationships: 1,3discuss approaches to rational drug design based on knowledge of the three-dimensional structure of biological targets: 1,3manipulate and present structural information for protein-ligand interactions using the protein data bank: 1communicate effectively in written and visual form through the production of a written report and group communication exercise: 1,2
24 hours in-situ lectures/tutorials supporting lecture content12 hours IT workshops6 hours CBL sessions2x2 hours preparation for CBL sessions12x 4 hours engagement with asynchronous activities including preparations for workshops,27 hours directed reading/engagement with additional resources and private study for exam preparation27 hours private study: preparation of in-course assessments2 hours exam
Description of Module Assessment
1: Report weighted 30%1,000 word reportStudents will produce a 1,000 word report assessing the presentation and interpretation of structural data for protein-ligand interactions using the protein data bank/other software for visualisation/manipulation.
2: Group Assessment weighted 20%Group communication exerciseWorking in groups (2-3) students will produce a patient information leaflet on an allocated pharmaceutical detailing key information on the function and biological activity of the molecule in context to disease treatment.
3: Exam weighted 50%Closed book exam (MCQs and SAQs)The unseen exam will consist of multiple-choice and short-answer questions assessing lecture-based material. While the exam is designed to take approximately 1 hour, all students will be allocated 2 hours to ensure an inclusive and accessible assessment experience. Students will be permitted to take a double-sided A4 memory prompt of notes with them to the exam.